FindTrial
Sign In

ursodeoxycholic acid (UDCA)

DRUG6 trials

Sponsors

University of Tennessee, Sahlgrenska University Hospital, Daewoong Pharmaceutical Co. LTD., Tishreen University Hospital, West China Hospital

Conditions

HealthyHepatic Encephalopathy (HE)Hyperbilirubinemia, Neonatal IndirectMorbid ObesityNon-alcoholic Fatty Liver DiseaseNutritional, Metabolic, Endocrine Hepatitis CPrimary Sclerosing CholangitisTIPS

Phase 1

Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
CompletedNCT01088607
University of TennesseePrimary Sclerosing Cholangitis
Start: 2010-10-31End: 2017-06-30Updated: 2017-10-26
A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects
CompletedNCT02622685
Daewoong Pharmaceutical Co. LTD.Healthy
Start: 2015-05-31End: 2016-02-29Updated: 2016-06-02

Unknown Phase

Ursodeoxycholic Acid in Bariatric Surgery
CompletedNCT01548079
Sahlgrenska University HospitalMorbid Obesity, Non-alcoholic Fatty Liver Disease
Start: 2008-10-31End: 2010-05-31Updated: 2013-12-03
Efficacy of Ginkgo biloba in HCV-patients
Active, not recruitingPACTR201609001765772
Dina Mohamed kamal El-GindyNutritional, Metabolic, Endocrine Hepatitis C
Start: 2012-12-05Target: 67Updated: 2026-09-14
The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia
RecruitingNCT07110987
Tishreen University HospitalHyperbilirubinemia, Neonatal Indirect
Start: 2025-06-26End: 2027-03-01Target: 70Updated: 2026-04-21
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
Not yet recruitingNCT07273734
West China HospitalHepatic Encephalopathy (HE), TIPS
Start: 2026-01-01End: 2027-12-31Target: 270Updated: 2025-12-09